https://medicaldialogues.in/diabetes-endocrinology/guidelines/sglt2i-reduce-hf-and-mace-and-improve-kidney-outcomes-in-ckd-states-ada-easd-consensus-report-99824
SGLT2 inhibitors reduce HF, MACE and improve kidney outcomes in CKD: ADA/ EASD consensus report